Channel Therapeutics Quote - CHRO

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.6203

Bid

Offer

Volume

166,800

0.562 Day's Range 0.65

0.45 52 Week Range 6.00

Market Cap

3.739M

Previous Close

0.653

Open

0.646

Last Trade

501

0.6435

Last Trade Time

Financial Volume

US$ 104,564

VWAP

0.62688

Average Volume (3m)

161,435

Shares Outstanding

6,028,011

Dividend Yield

PE Ratio

-0.52

Earnings Per Share (EPS)

-1.22

Revenue

Net Profit

-7.38M

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

channeltherapeutics.com

Headquarters

Reno, Nevada, USA

Founded

Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Channel Therapeutics was US$0.65. Over the last year, Channel Therapeutics shares have traded in a share price range of US$ 0.45 to US$ 6.00.

Channel Therapeutics currently has 6,028,011 shares in issue. The market capitalisation of Channel Therapeutics is US$3.94 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -0.52.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0691	-10.0232085872	0.6894	0.6894	0.5633	210299	0.59961457	CS
4	0.0013	0.210016155089	0.619	0.88	0.5513	163856	0.6990816	CS
12	-0.3496	-36.0449530879	0.9699	1.04	0.45	161435	0.73252942	CS
26	-0.7897	-56.0070921986	1.41	1.75	0.45	99675	0.80642223	CS
52	-5.3797	-89.6616666667	6	6	0.45	69129	1.06548021	CS
156	-5.3797	-89.6616666667	6	6	0.45	69129	1.06548021	CS
260	-5.3797	-89.6616666667	6	6	0.45	69129	1.06548021	CS

CHRO - Frequently Asked Questions (FAQ)

What is the current Channel Therapeutics share price?

The current share price of Channel Therapeutics is US$ 0.6203

How many Channel Therapeutics shares are in issue?

Channel Therapeutics has 6,028,011 shares in issue

What is the market cap of Channel Therapeutics?

The market capitalisation of Channel Therapeutics is USD 3.94M

What is the 1 year trading range for Channel Therapeutics share price?

Channel Therapeutics has traded in the range of US$ 0.45 to US$ 6.00 during the past year

What is the PE ratio of Channel Therapeutics?

The price to earnings ratio of Channel Therapeutics is -0.52

What is the reporting currency for Channel Therapeutics?

Channel Therapeutics reports financial results in USD

What is the latest annual profit for Channel Therapeutics?

The latest annual profit of Channel Therapeutics is USD -7.38M

What is the registered address of Channel Therapeutics?

The registered address for Channel Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501

What is the Channel Therapeutics website address?

The website address for Channel Therapeutics is channeltherapeutics.com

Which industry sector does Channel Therapeutics operate in?

Channel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MGLDMarygold Companies Inc	US$ 2.053 (48.77%)	128.45k
MINFT Limited	US$ 7.25 (44.22%)	948.89k
CTMCastellum Inc	US$ 0.578 (41.01%)	8.94M
KULRKULR Technology Group Inc	US$ 2.885 (28.79%)	75.72M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 12.49 (22.81%)	64.96M
BATLBattalion Oil Corporation	US$ 1.3499 (-44.56%)	1.63M
NVOXDefiance Daily Target 2x Long Nvo ETF	US$ 11.5991 (-35.47%)	407.1k
UVIX2x Long VIX Futures ETF	US$ 3.83 (-29.07%)	70.61M
TPETTrio Petroleum Corp	US$ 1.10 (-25.17%)	2.81M
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 19.235 (-23.06%)	21.33M
SPYSPDR S&P 500	US$ 591.15 (0.86%)	122.49M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6.1628 (-3.25%)	114.87M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 27.30 (3.80%)	108.08M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.435 (7.27%)	94.23M
KULRKULR Technology Group Inc	US$ 2.885 (28.79%)	75.72M